Balance Sheet

Current Liabilities	16.5m
Accounts Payable	2m
Accrued Liabilities	780.7k
Short-Term Debt	8.1m
Other Current Liabilities	5.7m
Non-Current Liabilities	1.4m
Long-Term Debt	1.9m
Other Non-Current Liabilities	-518.6k

Currency: USD

	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	30	27	4	1	1	0	0	1	0	0
Cash Equivalents	30	27	4	1	1	0	0	1	0	0
Short-Term Investments	0	0	9	0	0	0	0	0	0	0
Total Receivables	0	0	0	0	0	0	0	0	0	0
Accounts Receivables	0	0	0	0	0	0	0	0	0	0
Other Receivables	0	0	0	0	0	0	0	0	0	0
Other Current Assets	0	0	2	0	0	0	0	0	0	0
Total Current Assets	30	27	14	1	1	0	1	1	0	0
PP&E Net	0	0	0	0	0	0	0	0	0	0
PP&E Gross	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	2	2	2	1	1
Goodwill	0	0	0	0	0	21	21	21	12	6
Long-Term Investments	0	0	0	0	0	0	0	0	23	23
Other Long-Term Assets	0	0	0	0	0	0	0	0	0	0
Other Assets	0	0	0	0	0	21	21	21	12	6
Total Assets	30 N/A	27 -10%	14 -49%	1 -92%	1 -32%	24 +2 860%	24 0%	24 0%	36 +53%	30 -17%
Liabilities
Accounts Payable	0	0	0	1	1	2	2	2	2	2
Accrued Liabilities	1	2	1	1	0	0	1	1	1	1
Short-Term Debt	0	0	0	0	0	1	3	5	11	8
Current Portion of Long-Term Debt	0	0	0	0	0	0	2	4	0	3
Other Current Liabilities	0	0	0	0	0	3	3	3	3	3
Total Current Liabilities	1	2	2	2	1	7	11	15	17	17
Long-Term Debt	0	0	0	0	0	0	0	0	0	2
Minority Interest	0	0	0	0	0	0	1	0	0	1
Total Liabilities	1 N/A	2 +48%	2 -23%	2 +2%	1 -30%	7 +484%	12 +75%	16 +32%	17 +7%	18 +7%
Equity
Common Stock	0	0	0	0	0	1	1	4	4	4
Retained Earnings	251	265	278	292	295	12	22	31	26	34
Additional Paid In Capital	280	290	291	292	294	28	32	35	41	42
Total Equity	29 N/A	25 -13%	13 -51%	0 N/A	0 +25%	17 N/A	12 -30%	8 -32%	19 +144%	12 -38%
Total Liabilities & Equity	30 N/A	27 -10%	14 -49%	1 -92%	1 -32%	24 +2 860%	24 0%	24 0%	36 +53%	30 -17%
Shares Outstanding
Common Shares Outstanding	21	27	27	27	41	84	91	375	392	399
Preferred Shares Outstanding	0	0	0	0	0	0	0	0	0	0

Oncotelic Therapeutics Inc
OTC:OTLC